What’s Material in ESG for Biopharma Firms?
Manage episode 291745531 series 2838531
For biopharma companies, ESG commitments can look considerably different from other sectors. We spoke with the team of ESG leads at Gilead Sciences to understand the five key components driving its ESG strategy, how it’s evolved and how it impacts their business.
33 episodes